Search results for "suppression"

showing 10 items of 404 documents

Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development

2020

Background: miRNAs are master regulators of signaling pathways critically involved in asthma and are transferred between cells in extracellular vesicles (EV). We aimed to investigate whether the miRNA content of EV secreted by primary normal human bronchial epithelial cells (NHBE) is altered upon asthma development. Methods: NHBE cells were cultured at air-liquid interface and treated with interleukin (IL)-13 to induce an asthma-like phenotype. EV isolations by precipitation from basal culture medium or apical surface wash were characterized by nanoparticle tracking analysis, transmission electron microscopy, and Western blot, and EV-associated miRNAs were identified by a RT-qPCR-based prof…

MaleEXPRESSIONMECHANISMAdolescentMICRORNASImmunologyRespiratory MucosaBiologyDENDRITIC CELLSTh2 CellsWestern blotmicroRNAmedicineImmunology and AllergyHumansSecretionChildCells CulturedmiRNASUPPRESSIONInterleukin-13LAVAGE FLUID EXOSOMESmedicine.diagnostic_testInterleukinCell PolarityCell DifferentiationEpithelial Cellsairway epitheliumDendritic cellExtracellular vesiclePROFILESrespiratory systemasthmaDYSFUNCTIONCell biologyddc:Th2 polarizationNasal LavageRespiratory epitheliumFemaleSignal transductionTranscriptomeextracellular vesiclesSignal Transduction
researchProduct

Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma.

2005

Background: The presence of Human Herpesvirus-8 (HHV8) DNA is predictive of Kaposi sarcoma (KS) among patients with HIV-associated or iatrogenic immunosuppression. However, correlates of HHV8-DNA detection in the general population remain undefined. Methods: We assessed correlates of HHV8-DNA detection among Italian adults without KS who had antibodies against HHV8-latent nuclear antigen by immunofluorescence assay. HHV8-K6 DNA sequences were detected in peripheral blood mononuclear cells using TaqMan CR. Results: Of the 158 subjects 26 (16.5%) had detectable HHV8-DNA [median copies/million cells, 53; (13-2128)]. Adjusted for age, sex, and laboratory, HHV8-DNA was detected more frequently i…

MaleEpidemiologymedicine.medical_treatmentComorbiditySettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeKaposi sarcoma herpesvirus80 and overLeukocytesGammaherpesvirinaeMedicineHHV8ViralAged 80 and overeducation.field_of_studybiologyvirus diseasesImmunosuppressionGeneral MedicineHerpesviridae InfectionsMiddle AgedViral LoadItalyHerpesvirus 8 HumanFemaleAntibodyKaposi sarcoma herpesviruViral loadHumanAdultViral DNAPopulationMononuclearKSHVPeripheral blood mononuclear cellHerpesviridaeAge DistributionAntigenHumansHerpesvirus 8Sex DistributioneducationAgedbusiness.industryHemodynamicsDNAbiology.organism_classificationBlood Cell CountSocioeconomic FactorsImmunologyDNA Viralbiology.proteinLeukocytes MononuclearbusinessInternational journal of epidemiology
researchProduct

Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) Inhibition of 19 S and 7 S plaque-forming cells in the p…

1975

The kinetics of the reactive cell clones after primary and secondary immunization with SRBC1) modified by cyclophosphamide and a newly synthesized cyclophosphamide analogue 036.5122 (Asta), have been studied. After primary immunization, both substances caused a severe and dose dependent depletion of 19 S PFC2). The 7 S PFC in the late primary response were only slightly inhibited by cyclophosphamide in low dose ranges, indicating, that sensitization could not be prevented by this substance. In contrast, 0.36.5122 was fully able to suppress 7 S PFC. Thus, treatment with 0.36.5122 after primary immunization can fully prevent the expression of the specific response. Experiments dealing with in…

MaleErythrocytesCyclophosphamidemedicine.medical_treatmentImmunologyCellHemolytic Plaque TechniqueMice Inbred StrainsBiologyToxicologyMiceAntigenImmune TolerancemedicineAnimalsPotencyCytotoxic T cellPharmacology (medical)Cells CulturedSensitizationImmunosuppression TherapyPharmacologyImmunity CellularImmunosuppressionClone Cellsmedicine.anatomical_structureImmunizationImmunologyFemaleSpleenmedicine.drugAgents and Actions
researchProduct

Comparing MEG and EEG in detecting the ~20-Hz rhythm modulation to tactile and proprioceptive stimulation

2020

Abstract Modulation of the ~20-Hz brain rhythm has been used to evaluate the functional state of the sensorimotor cortex both in healthy subjects and patients, such as stroke patients. The ~20-Hz brain rhythm can be detected by both magnetoencephalography (MEG) and electroencephalography (EEG), but the comparability of these methods has not been evaluated. Here, we compare these two methods in the evaluating of ~20-Hz activity modulation to somatosensory stimuli. Rhythmic ~20-Hz activity during separate tactile and proprioceptive stimulation of the right and left index finger was recorded simultaneously with MEG and EEG in twenty-four healthy participants. Both tactile and proprioceptive st…

MaleFINGERAudiologyElectroencephalographySomatosensory system0302 clinical medicineBeta RhythmEEGsensorimotor cortexPassive movementHZTactile stimulationMEGSensory stimulation therapyliikeaistimedicine.diagnostic_test05 social sciencesMagnetoencephalographyElectroencephalographySensorimotor cortexTouch PerceptionNeurologyEXCITABILITYtactile stimulationpassive movementstimulointiFemaleSENSITIVITYAdultmedicine.medical_specialtyBeta rhythmCognitive NeuroscienceBeta reboundStimulus (physiology)MOVEMENT BETA-SYNCHRONIZATIONbeta suppressiontuntoaisti050105 experimental psychologybeta rhythmlcsh:RC321-571FingersYoung Adult03 medical and health sciencesRhythmCORTICAL RHYTHMSPhysical StimulationOSCILLATIONSmedicineHumans0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatrymotoriikkaProprioceptionbusiness.industryPRIMARY MOTOR CORTEXEVENT-RELATED SYNCHRONIZATIONDESYNCHRONIZATIONbeta rebound3112 NeurosciencesSomatosensory CortexMagnetoencephalographyBeta suppressionProprioceptionbusiness030217 neurology & neurosurgeryNeuroImage
researchProduct

The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients.

1996

Haemodialysis patients often fail to respond to hepatitis B vaccination. In this pilot study, 15 patients previously non-responsive to at least three 40 micrograms doses of hepatitis B vaccine were given 0.5, 5 or 10 micrograms kg-1 granulocyte-macrophage colony-stimulating factor (GM-CSF) subcutaneously 24 h prior to booster vaccination with a hepatitis B vaccine. Seven of the 15 patients developed antibody to hepatitis B surface antigen (HBsAb) (35-7240 IU L-1) upon initial vaccination with GM-CSF and two of four individuals responded with low HBsAb titres of 15 and 60 IU L-1 when revaccinated with hepatitis B surface antigen (HBsAg) and twice the dose of GM-CSF. The application of GM-CSF…

MaleHBsAgHepatitis B vaccinemedicine.medical_treatmentmedicine.disease_causeAdjuvants ImmunologicRenal DialysisVirologyMedicineHumansHepatitis B VaccinesHepatitis B AntibodiesAdverse effectAgedHepatitis B virusHepatitis B Surface AntigensHepatologybiologybusiness.industryGranulocyte-Macrophage Colony-Stimulating FactorImmunosuppressionHepatitis BMiddle Agedmedicine.diseaseHepatitis BVaccinationInfectious DiseasesImmunologybiology.proteinFemaleAntibodyHypotensionbusinessJournal of viral hepatitis
researchProduct

Unconscious integration of multisensory bodily inputs in the peripersonal space shapes bodily self-consciousness

2017

International audience; Recent studies have highlighted the role of multisensory integration as a key mechanism of self-consciousness. In particular, integration of bodily signals within the peripersonal space (PPS) underlies the experience of the self in a body we own (self-identification) and that is experienced as occupying a specific location in space (self-location), two main components of bodily self-consciousness (BSC). Experiments investigating the effects of multisensory integration on BSC have typically employed supra-threshold sensory stimuli, neglecting the role of unconscious sensory signals in BSC, as tested in other consciousness research. Here, we used psychophysical techniq…

MaleLinguistics and LanguageUnconscious mindVisual perceptionConsciousnessCognitive Neurosciencemedia_common.quotation_subject[ SCCO.PSYC ] Cognitive science/PsychologyExperimental and Cognitive PsychologySensory systemPeripersonal spaceAffect (psychology)Visual awarenessLanguage and Linguistics050105 experimental psychologyPersonal Space03 medical and health sciences0302 clinical medicinePhysical StimulationPerceptionBody ImageDevelopmental and Educational PsychologyMultisensory integrationHumans[ SHS.ECO ] Humanities and Social Sciences/Economies and financesContinuous flash suppression0501 psychology and cognitive sciencesContinuous flash suppressionmedia_commonSensory stimulation therapy[SCCO.NEUR]Cognitive science/Neuroscience05 social sciencesMultisensory integrationAwarenessProprioception16. Peace & justice[SHS.ECO]Humanities and Social Sciences/Economics and FinanceSelf ConceptTouch Perception[ SCCO.NEUR ] Cognitive science/Neuroscience[SCCO.PSYC]Cognitive science/PsychologyVisual PerceptionFemaleConsciousnessPsychologyBodily self-consciousness030217 neurology & neurosurgeryCognitive psychology
researchProduct

Leishmaniasis, autoimmune rheumatic disease, and anti–tumor necrosis factor therapy, Europe.

2009

We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during 2004–2008, especially for patients treated with anti–tumor necrosis factor agents.

MaleNecrosisgenetic structuresEpidemiologymedicine.medical_treatmentAnti-Inflammatory Agentslcsh:MedicineAnti-TNF0302 clinical medicineRisk FactorsMedicine030212 general & internal medicinerheumatic diseaseLeishmaniasisLeishmaniaimmunosuppressionbiologyDispatchAntibodies MonoclonalRheumatic diseaseImmunosuppressionMiddle Aged3. Good healthEuropeTreatment OutcomeInfectious DiseasesRheumatic feverFemaleTumor necrosis factor alphaImmunotherapymedicine.symptomMicrobiology (medical)medicine.medical_specialtytumor necrosis factor030231 tropical medicineletterparasiteslcsh:Infectious and parasitic diseases03 medical and health sciencesRheumatic DiseasesAnimalsHumansautoimmune diseaseslcsh:RC109-216Letters to the EditorAged030203 arthritis & rheumatologyTumor Necrosis Factor-alphabusiness.industryscreeninglcsh:RLeishmaniasisImmunotherapyLeishmaniabiology.organism_classificationmedicine.diseaseDermatologyInfliximabAnti-Tumor Necrosis Factor TherapyImmunologysense organsbusinessEmerging Infectious Diseases
researchProduct

Autoimmune hepatitis in the elderly.

2001

Abstract OBJECTIVES: Autoimmune hepatitis (AIH) is widely believed to be a disease of young women and menopause. Little is known about the frequency and clinical characteristics in patients aged ≥65 yr. METHODS: We reviewed charts of 120 consecutive outpatients with known AIH to identify patients who were diagnosed at the age of 65 or older. These 20 patients (median age, 69 yr) were compared to the same number of younger patients (median age, 24 yr) with well-documented AIH from the same cohort. RESULTS: Seventeen percent (20/120) of our patients were ≥65 yr at the time of diagnosis. In the older patients median time to diagnosis was significantly longer than in the younger patients (8.5 >…

MalePediatricsmedicine.medical_specialtyTime FactorsJaundiceAutoimmune hepatitisCohort Studiesimmune system diseasesHLA AntigensMedicineHumansAgedAutoimmune diseaseHepatitisImmunosuppression TherapyHepatologybusiness.industryIncidence (epidemiology)Gastroenterologymedicine.diseasePrognosisdigestive system diseasesMenopauseHepatitis AutoimmuneCohortImmunologyFemaleAge of onsetbusinessCohort studyThe American journal of gastroenterology
researchProduct

Differential phenoloxidase activity between native and invasive gammarids infected by local acanthocephalans: differential immunosuppression?

2003

Manipulative endoparasites can alter the behaviour and the physiology of their intermediate hosts in ways that increase the probability of successful transmission to the final host. This requires that the parasite is able to circumvent its host's immune defence. Successful immune evasion may depend on host-parasite coevolutionary history and the appearance of new hosts invading the local host population may promote local parasite maladaptation. To test this hypothesis, we examined the effect of 2 acanthocephalan parasites, Pomphorhynchus laevis and Polymorphus minutus, on the immunity of their local and new invasive gammarid intermediate hosts, respectively Gammarus pulex and Gammarus roese…

MalePopulationZoologyAcanthocephalaHost-Parasite InteractionsImmune systemImmunityGammarus roeseliCrustaceaHemolymphAnimalseducationMaladaptationImmunosuppression Therapyeducation.field_of_studybiologyHost (biology)Monophenol Monooxygenasebiology.organism_classificationGammarus pulexInfectious DiseasesRegression AnalysisAnimal Science and ZoologyParasitologyPomphorhynchus laevisFemaleFranceParasitology
researchProduct

Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease

2015

Crohn's disease-related inflammation is characterized by reduced activity of the immunosuppressive cytokine transforming growth factor β1 (TGF-β1) due to high levels of SMAD7, an inhibitor of TGF-β1 signaling. Preclinical studies and a phase 1 study have shown that an oral SMAD7 antisense oligonucleotide, mongersen, targets ileal and colonic SMAD7.In a double-blind, placebo-controlled, phase 2 trial, we evaluated the efficacy of mongersen for the treatment of persons with active Crohn's disease. Patients were randomly assigned to receive 10, 40, or 160 mg of mongersen or placebo per day for 2 weeks. The primary outcomes were clinical remission at day 15, defined as a Crohn's Disease Activit…

MaleSMAD7 antisense oligonucleotidemedicine.medical_treatmentOligonucleotidesPharmacologyPLACEBO-CONTROLLED TRIALTHERAPYGastroenterologylaw.inventionACTIVATIONImmunosuppressive AgentGlucocorticoidRandomized controlled trialCrohn DiseaselawOligonucleotideMedicineYoung adultCrohn's diseaseSettore MED/12 - GastroenterologiabiologyINDUCTIONMedicine (all)Remission InductionGeneral MedicineMiddle AgedCrohn's diseaseCytokineC-Reactive ProteinCombinationDrug Therapy CombinationFemaleDrugImmunosuppressive AgentsCOLITISHumanAdultmedicine.medical_specialtyAdolescentINFLAMMATORY-BOWEL-DISEASE PLACEBO-CONTROLLED TRIAL NECROSIS-FACTOR-ALPHA TGF-BETA-1-MEDIATED SUPPRESSION COLITIS INDUCTION ACTIVATION EFFICACY THERAPY MICEPlaceboSmad7 ProteinDose-Response RelationshipYoung AdultPharmacotherapyDouble-Blind MethodDrug TherapyInternal medicineHumansAntisenseGlucocorticoidsAgedDose-Response Relationship Drugbusiness.industryC-reactive proteinNECROSIS-FACTOR-ALPHAOligonucleotides AntisenseTGF-BETA-1-MEDIATED SUPPRESSIONEFFICACYmedicine.diseaseClinical trialMICEbiology.proteinbusinessAdolescent; Adult; Aged; C-Reactive Protein; Crohn Disease; Dose-Response Relationship Drug; Double-Blind Method; Drug Therapy Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Oligonucleotides; Oligonucleotides Antisense; Remission Induction; Smad7 Protein; Young Adult; Medicine (all)INFLAMMATORY-BOWEL-DISEASE
researchProduct